Physician profile
Richard E White
NPI 1528210655
$3,925.57
in general payments reported to CMS, 2019-2025
37 companies · $1,338 in 2025
The $1,338 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $388 · 2022: $473 · 2023: $837 · 2024: $889 · 2025: $1,338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,064.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,091.57 | 2021-2025 | |
| Pfizer INC. | $436.57 | 2023-2025 | |
| Astrazeneca Pharmaceuticals Lp | $340.15 | 2021-2025 | Airsupra |
| Amgen INC. | $209.00 | 2021-2025 | Repatha, Otezla, Krystexxa |
| Alkermes, INC. | $185.10 | 2021-2025 | Aristada, Aristada Initio, Lybalvi |
| Lilly USA, LLC | $166.71 | 2021-2024 | Mounjaro |
| Novo Nordisk INC | $146.85 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Collegium Pharmaceutical, INC. | $118.40 | 2021-2024 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $118.32 | 2021-2025 | Xifaxan, Relistor |
| Inspire Medical Systems, INC. | $104.36 | 2023-2025 | Inspire |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $88.45 | 2022-2025 | Caplyta |
| Bayer Healthcare Pharmaceuticals INC. | $82.63 | 2022-2025 | |
| Neurocrine Biosciences, INC. | $75.89 | 2021-2024 | Ingrezza |
| Nevro Corp. | $70.59 | 2023-2024 | Senza |
| Teva Pharmaceuticals USA, INC. | $64.28 | 2024-2025 | Austedo Xr, Austedo Xr |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.